These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 16190748)
1. Ligand recognition by RAR and RXR receptors: binding and selectivity. Sussman F; de Lera AR J Med Chem; 2005 Oct; 48(20):6212-9. PubMed ID: 16190748 [TBL] [Abstract][Full Text] [Related]
2. Pyrazine arotinoids with inverse agonist activities on the retinoid and rexinoid receptors. García J; Khanwalkar H; Pereira R; Erb C; Voegel JJ; Collette P; Mauvais P; Bourguet W; Gronemeyer H; de Lera AR Chembiochem; 2009 May; 10(7):1252-9. PubMed ID: 19343742 [TBL] [Abstract][Full Text] [Related]
3. Design of selective nuclear receptor modulators: RAR and RXR as a case study. de Lera AR; Bourguet W; Altucci L; Gronemeyer H Nat Rev Drug Discov; 2007 Oct; 6(10):811-20. PubMed ID: 17906643 [TBL] [Abstract][Full Text] [Related]
4. Structural basis for isotype selectivity of the human retinoic acid nuclear receptor. Klaholz BP; Mitschler A; Moras D J Mol Biol; 2000 Sep; 302(1):155-70. PubMed ID: 10964567 [TBL] [Abstract][Full Text] [Related]
5. Determinants of retinoid X receptor transcriptional antagonism. Cavasotto CN; Liu G; James SY; Hobbs PD; Peterson VJ; Bhattacharya AA; Kolluri SK; Zhang XK; Leid M; Abagyan R; Liddington RC; Dawson MI J Med Chem; 2004 Aug; 47(18):4360-72. PubMed ID: 15317450 [TBL] [Abstract][Full Text] [Related]
6. Effects of retinoid ligands on RIP140: molecular interaction with retinoid receptors and biological activity. Farooqui M; Franco PJ; Thompson J; Kagechika H; Chandraratna RA; Banaszak L; Wei LN Biochemistry; 2003 Feb; 42(4):971-9. PubMed ID: 12549917 [TBL] [Abstract][Full Text] [Related]
7. Corepressor interaction differentiates the permissive and non-permissive retinoid X receptor heterodimers. Lammi J; Perlmann T; Aarnisalo P Arch Biochem Biophys; 2008 Apr; 472(2):105-14. PubMed ID: 18282463 [TBL] [Abstract][Full Text] [Related]
8. Computational analysis of the structural basis of ligand binding to the crustacean retinoid X receptor. Nagaraju GP; Prasad GL; Taliaferro-Smith L; Aruna BV; Naik BR; Sekhar YN Comp Biochem Physiol Part D Genomics Proteomics; 2010 Dec; 5(4):317-24. PubMed ID: 20937572 [TBL] [Abstract][Full Text] [Related]
9. RAR and RXR modulation in cancer and metabolic disease. Altucci L; Leibowitz MD; Ogilvie KM; de Lera AR; Gronemeyer H Nat Rev Drug Discov; 2007 Oct; 6(10):793-810. PubMed ID: 17906642 [TBL] [Abstract][Full Text] [Related]
10. Running increases neurogenesis without retinoic acid receptor activation in the adult mouse dentate gyrus. Aberg E; Perlmann T; Olson L; Brené S Hippocampus; 2008; 18(8):785-92. PubMed ID: 18493951 [TBL] [Abstract][Full Text] [Related]
11. Retinoid receptor subtype-selective modulators through synthetic modifications of RARgamma agonists. Alvarez S; Alvarez R; Khanwalkar H; Germain P; Lemaire G; Rodríguez-Barrios F; Gronemeyer H; de Lera AR Bioorg Med Chem; 2009 Jul; 17(13):4345-59. PubMed ID: 19482478 [TBL] [Abstract][Full Text] [Related]
12. Decreased expression of retinoid receptors in melanoma: entailment in tumorigenesis and prognosis. Chakravarti N; Lotan R; Diwan AH; Warneke CL; Johnson MM; Prieto VG Clin Cancer Res; 2007 Aug; 13(16):4817-24. PubMed ID: 17699860 [TBL] [Abstract][Full Text] [Related]
13. Agonist and antagonist of retinoic acid receptors cause similar changes in gene expression and induce senescence-like growth arrest in MCF-7 breast carcinoma cells. Chen Y; Dokmanovic M; Stein WD; Ardecky RJ; Roninson IB Cancer Res; 2006 Sep; 66(17):8749-61. PubMed ID: 16951191 [TBL] [Abstract][Full Text] [Related]
14. Manipulation of reciprocal salt bridges at the heterodimerization interface alters the dimerization properties of mouse RXRalpha and PPARgamma1. Chan LS; Wells RA Biochem Biophys Res Commun; 2007 Jul; 358(4):1080-5. PubMed ID: 17521607 [TBL] [Abstract][Full Text] [Related]
15. Nuclear retinoid receptors: mediators of retinoid effects. van der Saag PT Eur J Clin Nutr; 1996 Jul; 50 Suppl 3():S24-8. PubMed ID: 8841770 [TBL] [Abstract][Full Text] [Related]
16. Molecular recognition of docosahexaenoic acid by peroxisome proliferator-activated receptors and retinoid-X receptor alpha. Gani OA; Sylte I J Mol Graph Model; 2008 Sep; 27(2):217-24. PubMed ID: 18547851 [TBL] [Abstract][Full Text] [Related]
17. RARbeta ligand-binding domain bound to an SRC-1 co-activator peptide: purification, crystallization and preliminary X-ray diffraction analysis. Kammerer S; Germain P; Flaig R; Peluso-Iltis C; Mitschler A; Rochel N; Gronemeyer H; Moras D Acta Crystallogr D Biol Crystallogr; 2004 Nov; 60(Pt 11):2048-50. PubMed ID: 15502323 [TBL] [Abstract][Full Text] [Related]
18. Molecular dynamics, database screening, density functional and docking studies of novel RAR ligands in cancer chemotherapy. Silva CH; Taft CA Biophys Chem; 2005 Aug; 117(1):73-7. PubMed ID: 15908104 [TBL] [Abstract][Full Text] [Related]
19. Selective allosteric ligand activation of the retinoid X receptor heterodimers of NGFI-B and Nurr1. Morita K; Kawana K; Sodeyama M; Shimomura I; Kagechika H; Makishima M Biochem Pharmacol; 2005 Dec; 71(1-2):98-107. PubMed ID: 16288995 [TBL] [Abstract][Full Text] [Related]
20. Ab initio fragment molecular orbital study of molecular interactions in liganded retinoid X receptor: specification of residues associated with ligand inducible information transmission. Ito M; Fukuzawa K; Ishikawa T; Mochizuki Y; Nakano T; Tanaka S J Phys Chem B; 2008 Sep; 112(38):12081-94. PubMed ID: 18729504 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]